Early diagnosis of brain tumours through biofluid metabolomics
Objectives: Over 20% of cancer patients develop brain metastases. Current MRI diagnostic techniques only detect late stage metastases, since they rely on blood-brain-barrier permeability to allow contrast enhancement. Thus, new methods enabling earlier diagnosis are urgently needed. We have previous...
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Conference item |
| Έκδοση: |
SAGE Publications
2016
|